09:45 AM EST - Bausch Health Companies Inc. : Reported that its gastroenterology business known as Salix Pharmaceuticals will present four posters featuring data for XIFAXAN® (rifaximin) and RELISTOR® (methylnaltrexone bromide) at the Society of Hospital Medicine (SHM) Converge 2022 annual meeting taking place in Nashville, Tenn. on April 7-10. Bausch Health Companies Inc.
shares T.BHC are trading up $0.12 at $28.94.
